Search Results - "Hanna, Nasser"
-
1
Testicular Cancer — Discoveries and Updates
Published in The New England journal of medicine (20-11-2014)“…The treatment of testicular cancer is a success story in oncology. With available methods, 95% of men with this condition can be cured. Emphasis is shifting…”
Get full text
Journal Article -
2
Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline Update
Published in Journal of clinical oncology (10-05-2020)“…The aim of this work is to provide evidence-based recommendations updating the 2017 ASCO guideline on systemic therapy for patients with stage IV…”
Get full text
Journal Article -
3
High-Dose Chemotherapy and Autologous Peripheral-Blood Stem-Cell Transplantation for Relapsed Metastatic Germ Cell Tumors: The Indiana University Experience
Published in Journal of clinical oncology (01-04-2017)“…Purpose Patients with relapsed metastatic germ cell tumor (GCT) can be cured with second-line and even third-line regimens. We report survival outcomes of…”
Get full text
Journal Article -
4
Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO and OH (CCO) Joint Guideline Update
Published in Journal of clinical oncology (20-03-2021)“…To provide evidence-based recommendations updating the 2017 ASCO guideline on systemic therapy for patients with stage IV non-small-cell lung cancer (NSCLC)…”
Get full text
Journal Article -
5
Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
Published in Journal of clinical oncology (20-10-2017)“…Purpose Provide evidence-based recommendations updating the 2015 ASCO guideline on systemic therapy for patients with stage IV non-small-cell lung cancer…”
Get full text
Journal Article -
6
A phase 2 trial of consolidation pembrolizumab following concurrent chemoradiation for patients with unresectable stage III non–small cell lung cancer: Hoosier Cancer Research Network LUN 14‐179
Published in Cancer (01-10-2020)“…Background Five‐year overall survival (OS) for patients with unresectable stage III non–small cell lung cancer (NSCLC) is poor. Until recently, a standard of…”
Get full text
Journal Article -
7
A phase 2 trial of chemotherapy plus pembrolizumab in patients with advanced non–small cell lung cancer previously treated with a PD‐1 or PD‐L1 inhibitor: Big Ten Cancer Research Consortium BTCRC‐LUN15‐029
Published in Cancer (15-01-2023)“…Background Immunotherapy using a checkpoint inhibitor (CPI) alone or in combination with chemotherapy is the standard of care for treatment‐naive patients with…”
Get full text
Journal Article -
8
The Differential Efficacy of Pemetrexed According to NSCLC Histology: A Review of Two Phase III Studies
Published in The oncologist (Dayton, Ohio) (01-03-2009)“…Background. Recent studies of pemetrexed have identified a predictive role for non‐small cell lung cancer (NSCLC) histology. We further reviewed the…”
Get full text
Journal Article -
9
The SMILE scale: a wellness behavioral tool for patients with cancer
Published in Quality of life research (04-09-2024)“…As cancer survivorship increases, there is a need for simple tools to measure and promote healthy behaviors. We created a wellness behavioral tool (the SMILE…”
Get full text
Journal Article -
10
Tobacco Cessation and Control a Decade Later: American Society of Clinical Oncology Policy Statement Update
Published in Journal of clinical oncology (01-09-2013)Get full text
Journal Article -
11
Management of Residual Nonretroperitoneal Disease in Postchemotherapy Nonseminomatous Germ-Cell Tumors
Published in Journal of clinical oncology (10-08-2023)“…The majority of patients with advanced nonseminomatous germ-cell tumor are cured with combination chemotherapy and surgical resection of residual disease when…”
Get full text
Journal Article -
12
Primary Retroperitoneal Lymph Node Dissection for Stage II Seminoma: Is Surgery the New Path Forward?
Published in Journal of clinical oncology (10-08-2023)“…On the basis of National Comprehensive Cancer Network guidelines, clinical stage (CS) II seminoma is treated with radiotherapy or chemotherapy. Primary…”
Get full text
Journal Article -
13
Phase I/II trial of plinabulin in combination with nivolumab and ipilimumab in patients with recurrent small cell lung cancer (SCLC): Big ten cancer research consortium (BTCRC-LUN17-127) study
Published in Lung cancer (Amsterdam, Netherlands) (01-09-2024)“…•Plinabulin is a GEF-H1 releasing agent with an immune-enhancing function.•We report results from a Phase I/II study for recurrent small cell lung cancer.•The…”
Get full text
Journal Article -
14
Impact of smoke-free ordinance strength on smoking prevalence and lung cancer incidence
Published in PloS one (16-04-2021)“…Smoke-free ordinances (SFO) have been shown to be effective public health interventions, but there is limited data on the impact SFO on lung cancer outcomes…”
Get full text
Journal Article -
15
A phase II study assessing the safety and efficacy of ASP1650 in male patients with relapsed refractory germ cell tumors
Published in Investigational new drugs (01-10-2022)“…Claudin6(CLDN6) is a tight junction protein of claudin-tetraspanin family and is of the earliest molecules expressed in embryonic epithelium. CLDN6 is…”
Get full text
Journal Article -
16
Phase III Study of Carboplatin and Paclitaxel Alone or With Sorafenib in Advanced Non–Small-Cell Lung Cancer
Published in Journal of clinical oncology (10-04-2010)“…PURPOSE This phase III, multicenter, randomized, placebo-controlled trial assessed the efficacy and safety of sorafenib, an oral multikinase inhibitor, in…”
Get full text
Journal Article -
17
Phase III Study of Cisplatin, Etoposide, and Concurrent Chest Radiation With or Without Consolidation Docetaxel in Patients With Inoperable Stage III Non–Small-Cell Lung Cancer: The Hoosier Oncology Group and U.S. Oncology
Published in Journal of clinical oncology (10-12-2008)“…Concurrent chemoradiotherapy is standard treatment for patients with inoperable stage III non-small-cell lung cancer (NSCLC). A phase II study by the Southwest…”
Get full text
Journal Article -
18
Surveillance after Complete Response to First-Line Chemotherapy in Patients with Metastatic Nonseminomatous Germ Cell Tumor
Published in The Journal of urology (01-09-2022)“…PURPOSEThe optimal management of patients with metastatic germ cell tumors who achieve a complete response (CR) after first-line chemotherapy remains…”
Get full text
Journal Article -
19
Nintedanib plus pemetrexed versus placebo plus pemetrexed in patients with relapsed or refractory, advanced non-small cell lung cancer (LUME-Lung 2): A randomized, double-blind, phase III trial
Published in Lung cancer (Amsterdam, Netherlands) (01-12-2016)“…Highlights • Nintedanib plus docetaxel improved PFS for pretreated NSCLC compared with docetaxel in LUME-Lung 1. • LUME-Lung 2 investigated nintedanib plus…”
Get full text
Journal Article -
20
Survival outcomes and toxicity in patients 40 years old or older with relapsed metastatic germ cell tumors treated with high‐dose chemotherapy and peripheral blood stem cell transplantation
Published in Cancer (15-10-2021)“…BACKGROUND High‐dose chemotherapy (HDCT) plus peripheral blood stem cell transplantation (PBSCT) is effective salvage therapy for relapsed metastatic germ cell…”
Get full text
Journal Article